Impaired negative feedback of the non-canonical NF-κB signaling is associated with autoimmune diseases, such as systemic lupus erythematosus (SLE), and IBD (14, 36, 37) and the sustained NIK signaling is considered as an oncogenic event in diffuse large B-cell lymphoma (38). Here, NFKB1 is linked to inflammatory bowel disease.